14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Two bills have been introduced in the Senate that would allow employers to make matching contributio...
Read More >
Restrictive covenant matters rarely make it through the appellate courts. This is true for a number ...
Read More >
A majority of employers (60%) are not only conducting analyses to identify and address pay equity is...
Read More >
The sixth of a six-part series examining six specific and evolving rights plan provisions. As discu...
Read More >
A recent McDermott round table on European health private equity generated key insights into the fut...
Read More >
As the COVID-19 pandemic continues, owners and developers find themselves facing the prospect of con...
Read More >